Centaurus Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.91M Buy
7,176
+534
+8% +$217K 0.17% 136
2025
Q1
$3.31M Sell
6,642
-13
-0.2% -$6.47K 0.2% 114
2024
Q4
$3.46M Buy
6,655
+153
+2% +$79.6K 0.21% 103
2024
Q3
$4.02M Buy
6,502
+219
+3% +$135K 0.26% 89
2024
Q2
$3.48M Buy
6,283
+201
+3% +$111K 0.23% 102
2024
Q1
$3.54M Buy
6,082
+151
+3% +$87.8K 0.25% 97
2023
Q4
$3.15M Buy
5,931
+546
+10% +$290K 0.24% 97
2023
Q3
$2.73M Buy
5,385
+831
+18% +$421K 0.24% 99
2023
Q2
$2.38M Sell
4,554
-574
-11% -$299K 0.21% 124
2023
Q1
$2.96M Buy
5,128
+549
+12% +$316K 0.24% 112
2022
Q4
$2.52M Sell
4,579
-711
-13% -$392K 0.24% 112
2022
Q3
$2.68M Buy
5,290
+397
+8% +$201K 0.26% 99
2022
Q2
$2.66M Sell
4,893
-47
-1% -$25.5K 0.26% 102
2022
Q1
$2.92M Sell
4,940
-180
-4% -$106K 0.23% 113
2021
Q4
$3.42M Sell
5,120
-45
-0.9% -$30K 0.26% 97
2021
Q3
$2.95M Buy
5,165
+91
+2% +$52K 0.25% 98
2021
Q2
$2.56M Buy
5,074
+4,294
+551% +$2.17M 0.22% 116
2021
Q1
$356K Buy
780
+95
+14% +$43.4K 0.04% 458
2020
Q4
$319K Sell
685
-50
-7% -$23.3K 0.03% 454
2020
Q3
$324K Buy
735
+193
+36% +$85.1K 0.04% 356
2020
Q2
$196K Buy
542
+36
+7% +$13K 0.03% 427
2020
Q1
$144K Buy
506
+11
+2% +$3.13K 0.03% 415
2019
Q4
$161K Buy
+495
New +$161K 0.02% 503
2019
Q3
Sell
-1,008
Closed -$296K 575
2019
Q2
$296K Buy
1,008
+739
+275% +$217K 0.05% 356
2019
Q1
$983 Sell
269
-11
-4% -$40 0.01% 527
2018
Q4
$1 Buy
280
+279
+27,900% +$1 0.01% 460
2018
Q3
$366 Sell
1
-1,498
-100% -$548K 0.07% 282
2018
Q2
$311K Buy
1,499
+137
+10% +$28.4K 0.04% 409
2018
Q1
$281K Buy
+1,362
New +$281K 0.07% 270